CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 92 filers reported holding CUE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 2.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $591,618 | -37.0% | 257,225 | 0.0% | 0.08% | -31.7% |
| Q2 2023 | $938,871 | +2.2% | 257,225 | 0.0% | 0.12% | -20.5% |
| Q1 2023 | $918,293 | +25.3% | 257,225 | 0.0% | 0.15% | +118.8% |
| Q4 2022 | $733,091 | +27.7% | 257,225 | 0.0% | 0.07% | +23.2% |
| Q3 2022 | $574,000 | -10.3% | 257,225 | 0.0% | 0.06% | -9.7% |
| Q2 2022 | $640,000 | -49.0% | 257,225 | 0.0% | 0.06% | -38.6% |
| Q1 2022 | $1,255,000 | -56.9% | 257,225 | 0.0% | 0.10% | -55.9% |
| Q4 2021 | $2,909,000 | -22.0% | 257,225 | +0.5% | 0.23% | -4.6% |
| Q3 2021 | $3,730,000 | +25.1% | 256,000 | 0.0% | 0.24% | +22.4% |
| Q2 2021 | $2,982,000 | -4.5% | 256,000 | 0.0% | 0.20% | -10.9% |
| Q1 2021 | $3,123,000 | – | 256,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
| Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
| P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
| Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
| Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
| Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
| PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
| SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
| Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |